Literature DB >> 34699976

The spectrum of macrophage-predominant inflammatory myocardial disease presenting as fulminant heart failure.

Bruce I Goldman1, Hae-Yoon Choung2, Michele Sainvil3, Christa-Whitney Miller2.   

Abstract

BACKGROUND: Endomyocardial biopsy results are integral for diagnosis and management of myocarditis. Current diagnostic classifications of myocarditis are based on the microscopic and immunochemical characterization of inflammation do not include monocyte/macrophage-predominant (i.e. "histiocytic") myocarditis as a histologic subtype.
METHODS: Endomyocardial biopsies from 6 patients with sudden heart failure were reviewed by 3 cardiac pathologists. Routine stains and immunostains to identify T cells and monocytes/macrophages, complement C4d, and endothelium were applied. Electron microscopy was performed in 2 cases.
RESULTS: The 6 patients included 2 with diagnoses of systemic lupus erythematosus (SLE) and 4 without known disease. Microscopy showed space-occupying inflammation in 2 cases and interstitial inflammation in 4. No giant cell myocarditis or eosinophilic myocarditis was found. Immunostains showed infiltration predominantly by macrophages and/or monocytes with markedly fewer T cells. In 4 of 6 cases necrotic cells were immunopositive for complement C4d. Monocytes we identified immunochemically within the microvasculature in 5 cases and by electron microscopy in 2. Patients with SLE had microvascular C4d positivity or interstitial/sarcolemmal staining. Clinical outcomes ranged from spontaneous resolution to persistent heart failure requiring an internal cardioverter/defibrillator.
CONCLUSIONS: (1) Heart failure with CD68 predominant inflammation ("histiocytic" myocardial inflammatory disease, HMID) occurs with variable clinical presentation and outcome; (2) HMID may be primary or secondary; (3) some cases of HMID show features suggestive of antibody and/or complement mediated myocardial injury, and (4) HMID is a diagnosis distinct from those in classification systems currently in use.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Endomyocardial biopsy; Heart failure; Myocarditis

Mesh:

Year:  2021        PMID: 34699976     DOI: 10.1016/j.carpath.2021.107393

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  2 in total

1.  Diffuse mononuclear inflammatory response to COVID-19: friendly fire or smoldering enemy?

Authors:  Richard S Vander Heide
Journal:  Cardiovasc Pathol       Date:  2022-02-05       Impact factor: 2.185

2.  "Role of Cardiac Inflammation in the Pathology of COVID-19; relationship to the current definition of myocarditis".

Authors:  Sharon E Fox; R S Vander Heide
Journal:  Cardiovasc Pathol       Date:  2022-05-03       Impact factor: 3.975

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.